Imugene Limited

ASX:IMU ISIN:AU000000IMU9

Imugene Limited ASX IMUImugene Limited (ASX:IMU) is a clinical stage immuno-oncology company headquartered in Melbourne, Australia. Its lead product is HER-Vaxx, a B Cell peptide vaccine for the treatment of gastric cancer. The company is also developing mimotope-based immunotherapies against validated and new oncology targets.

HER-Vaxx is a cancer immunotherapy designed to treat tumours that over-express the HER-2/neu receptor, such as gastric, breast, ovarian, lung and pancreatic cancers. This unique immunotherapy, developed by leading scientists at the Medical University of Vienna in Austria, is a peptide vaccine constructed from various B cell epitopes of HER-2/neu. It has been shown in pre-clinical work and in one Phase 1 study to stimulate a potent polyclonal antibody response to HER-2/neu, a well-known and validated cancer target. HER-Vaxx's successful Phase 1 study was in patients with breast cancer and the next stage of development will be a Phase 1b/2 study in patients with gastric cancer initiating in 2016.

 
    
        

Sprache wählen

News

Australischer Marktbericht vom 16. September 2010: Conquest Mining Limited (ASX:CQT) schließt einen Gold-Silber-Kupfer Offtakevertrag mit Shandong Guoda Gold ab.

🕔9/16/2010 1:30:08 PM 12673

Australischer Marktbericht vom 16. September 2010 inkludiert: Conquest Mining (ASX:CQT) schloss einen Offtakevertrag für den Verkauf von Gold-Silber-Kupfer Konzentraten von seinem V2 Deopot in Mt. Carlton ab, Heemskirk Consolidated Limited (ASX:HSK) gab die Unterzeichnung eines Abkommens mit Conquest Mining Limited (ASX:CQT) bekannt, Imugene Limited (ASX:IMU) gab heute bekannt, dass sie erfolgreich den zweiten Test ihres Porcine Reproductive and Respiratory Syndrom (PRRS) Impfstoffs beendet haben und Synthesis Energy Systems Inc. (NASDAQ:SYMX) und Coalworks Limited (ASX:CWK) gaben heute eine gemeinsame Präsentation betitelt "Production of Liquid Fuels from Oaklands Coal Utilizing U-GAS(R) and MTG Technologies" (die Produktion von flüssigen Brennstoff von Oaklands Coal Utilizing U-GAS(R) und MTG Technologies).

Lesen Sie die komplette Artikel
###

74,577 COMPANY PROFILE VIEWS

  • Diese Seite wurde besucht: (letzten 7 Tagen: 11) (letzten 30 Tagen: 47) (seit Veröffentlichung: 7778) 

Company Data

    Headquarters
  • Suite 1, 1233 High Street
    Armadale, VIC 3143
    Australia
  • Telephone
  • +61-3-9824-5254 
  • Fax
  • +61-3-9822-7735 
  • Principal Sector
  • Gesundheit & Pharm 
  • Principal Industry
  • Biotechnology 
  • Homepage
  • www.imugene.com

More News Results

  • 2024/03/11: Phase 1 onCARlytics Trial Advances to Combination Arm*
  • 2024/02/29: Half Yearly Report and Accounts*
*refer to company website

Social Media